UNH UNITEDHEALTH GROUP INC
Hospital & Medical Service Plans · NYSE · SEC CIK 731766 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY3.3%
TTM net income YoY-9.7%
TTM EPS YoY-8.7%
Revenue 3-yr CAGR7.7%
Net income 3-yr CAGR-9.9%
Margins
Gross margin—
Operating margin5.3%
Net margin3.5%
FCF margin5.1%
EBITDA margin6.3%
Returns
ROE16.4%
ROA5.1%
ROIC (approx.)13.7%
Asset turnover1.43x
Leverage & solvency
Liabilities / assets66.3%
Debt / equity0.76x
Current ratio0.74x
Interest coverage6.21x
Cash quality & payout
Operating cash flow / net income1.65x
Accruals ratio-3.3%
Payout ratio51.4%
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $447.57B | $400.28B |
| Cost of revenue | $50.66B | $46.69B |
| SG&A expense | $59.59B | $53.01B |
| Operating income | $18.96B | $32.29B |
| Interest expense | $4.00B | $3.91B |
| Pretax income | $14.70B | $20.07B |
| Income tax | $1.89B | $4.83B |
| Net income | $12.06B | $14.40B |
| EBITDA | $23.32B | $36.39B |
| EPS (basic) | 13.28 | 15.64 |
| EPS (diluted) | 13.23 | 15.51 |
| Dividends declared per share | 8.73 | 8.18 |
| Weighted avg. shares (diluted) | 911.00M | 929.00M |
| Balance sheet | ||
| Cash & equivalents | $24.36B | $25.31B |
| Short-term investments | $3.76B | $3.80B |
| Receivables | $23.02B | $22.36B |
| Inventory | $3.30B | $3.80B |
| Current assets | $90.58B | $85.78B |
| PP&E, net | $10.76B | $10.55B |
| Goodwill | $110.50B | $106.73B |
| Intangibles | $20.47B | $23.27B |
| Total assets | $309.58B | $298.28B |
| Current liabilities | $114.90B | $103.77B |
| Short-term debt | $6.07B | $4.54B |
| Long-term debt | $72.32B | $72.36B |
| Total debt | $78.39B | $76.90B |
| Total liabilities | $207.88B | $195.69B |
| Shareholders' equity | $94.11B | $92.66B |
| Net debt | $54.02B | $51.59B |
| Shares outstanding | 906.00M | 915.00M |
| Cash flow statement | ||
| Operating cash flow | $19.70B | $24.20B |
| Capital expenditure | $3.62B | $3.50B |
| Free cash flow | $16.07B | $20.70B |
| Investing cash flow | -$8.69B | -$20.53B |
| Financing cash flow | -$11.64B | -$3.51B |
| Depreciation & amortization | $4.36B | $4.10B |
| Stock-based compensation | $971.00M | $1.02B |
| Dividends paid | $7.92B | $7.53B |
| Share buybacks | $5.54B | $9.00B |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.